AAAAI 2015 Annual Meeting - Houston, TX
AAAAI 2015 Annual Meeting - Houston, TX

AAAAI 2015 Annual Meeting

February 20-24, Houston, Texas

Press Events

All of the following press events will take place in the George R. Brown Convention Center, Level Three, Room 381B.

Saturday, February 21

WHEALS Birth Cohort: Allergic Diseases & The Microbiome @ 12:30 - 1:30 pm CT

“The Infant Gut Microbiome Mediates the Association Between Breastfeeding and Allergic-like Response to Pets in Children” (Abstract 504)

“Influence of Infant Gut Microbiome on Development of Infant Regulatory T Cells” (Abstract 327)

“Maternal and Birth Characteristics Are Associated with Infant Gut Microbial Composition” (Abstract 503)

“Breastfeeding Is Associated with Infant Gut Microbial Composition” (Abstract 548)

“Infant Gut Microbial Composition Alters IgE Response to Tetanus Toxoid Immunization” (Abstract 888)

“Association of Infant Gastrointestinal Microbiome with Nocturnal Symptoms in Children with Asthma” (Abstract 889)

Susan Lynch, PhD, University of California in San Francisco*

Christine Cole Johnson, PhD, MPH, FAAAAI, Henry Ford Hospital in Detroit

Dennis Ownby, MD, FAAAAI, Georgia Regents Health System in Georgia

*For more information, please note that Dr. Lynch will be participating in an Annual Meeting session on Saturday, February 21 @ 8:15 - 9:45 a.m. titled, How the Microbial Environment Influences the Development of Allergic Diseases: What We Know and What We Can Do?”

Sunday, February 22

Up-and-Coming Treatments @ 11:00 am - 12:00 pm CT

“High Rate of Sustained Unresponsiveness with Early-Intervention Peanut Oral Immunotherapy” (Abstract 506)

Brian P. Vickery, MD, FAAAAI, UNC-Chapel Hill

“Safety of 3-Injection Immunotherapy Protocol for Treating Grass Pollen-Induced Rhinoconjunctivitis in Adolescents/Young Adults” (Abstract L22)

Amber M. Patterson, MD, Nationwide Children's Hospital in Ohio

“Epicutaneous Immunotherapy (EPIT) Is Effective and Safe to Treat Peanut Allergy: A Multi-National Double-Blind Placebo-Controlled Randomized Phase IIb Trial” (Abstract L28)

Hugh A. Sampson, MD, FAAAAI, Icahn School of Medicine at Mount Sinai in New York

Monday, February 23

New Discoveries in Asthma @ 11:00 am - 12:00 pm

“Longitudinal Patterns of Skin Prick Test Sensitization in Early Childhood Predicts Risk for Asthma at Age 7” (Abstract 740)

David I. Bernstein, MD, FAAAAI, Bernstein Allergy Group, Inc. in Ohio

Jessica S. Tan, MD, MPH, University of Cincinnati in Ohio

“Rhinovirus Species and Asthma Exacerbations in Inner-City Children” (Abstract 528)

James E. Gern, MD, FAAAAI, University of Wisconsin-Madison School of Medicine and Public Health in Wisconsin

Ann T. Esquivel, MD, University of Wisconsin-Madison School of Medicine and Public Health in Wisconsin

Learning Early About Peanut (LEAP) Study @ 4:45 - 5:30 pm

“Randomized Trial of Peanut Consumption in Infants at Risk of Peanut Allergy” (full paper on LEAP study to be published in the New England Journal of Medicine (NEJM), embargo will lift at 3:30 p.m. CT on Monday, February 23) Read the NEJM paper here.

Jeffrey M. Drazen, MD, FAAAAI, NEJM Editor-in-Chief (Moderator)

Gideon Lack, MD, King’s College in London*

George Du Toit, MD, Evelina London Children's Hospital & The Portland Hospital in London

Daniel Rotrosen, MD, Director of NIAID's Division of Allergy, Immunology and Transplantation

James R. Baker, Jr., MD, FAAAAI, Chief Executive Officer and Chief Medical Officer of Food Allergy Research & Education

*For more information, please note that Professor Lack will be speaking during the Cutting Edge Keynote on Monday, February 23 @ 3:30 p.m. titled, The LEAP Study: Can Peanut Allergy be Prevented through Oral Tolerance Induction?” The embargo on the accompanying New England Journal of Medicine paper will lift at this time.